Serum and plasma separator -- constrictionless type

Ayres June 24, 1

Patent Grant 3891553

U.S. patent number 3,891,553 [Application Number 05/446,363] was granted by the patent office on 1975-06-24 for serum and plasma separator -- constrictionless type. This patent grant is currently assigned to Becton, Dickinson and Company. Invention is credited to Waldemar A. Ayres.


United States Patent 3,891,553
Ayres June 24, 1975

Serum and plasma separator -- constrictionless type

Abstract

A self-contained fluid separator assembly capable of separating blood into its component parts of plasma or serum, the light phase, and cellular portion, the heavy phase, is disclosed. The assembly comprises a container having a first open end for receiving blood for subsequent separation, a second open end for removing separated plasma or serum and closures sealing the open ends of the container, the closures being formed of a self sealing elastomeric material which is penetrable by a cannula. A piston is slidably disposed in the container having its lateral outer surfaces in sealing contact with the inner surface of the container. Pressure responsive valve means is provided on the piston which is normally closed when there is a minimum pressure differential on each side of the piston and the valve means automatically opens in response to a substantial pressure differential so that when the container is subjected to centrifugal force the blood separates into its light phase and heavy phase and the valve means automatically opens with the light phase passing through the valve means so that the piston moves down through the light phase while retaining sealing engagement with the inner surface of the container. Filter means is mounted on the piston so as to filter the light phase prior to its reaching the valve means. When the piston descends to the interface the heavy phase cellular material clogs the filter, thereby preventing flow of fluids and solids to the valve. The incompressible heavy phase beneath the piston stops further piston descent, the pressure differential is terminated and the valve means automatically shifts from the open position to the closed position to provide an impervious barrier between the separated phases of the blood.


Inventors: Ayres; Waldemar A. (Rutherford, NJ)
Assignee: Becton, Dickinson and Company (East Rutherford, NJ)
Family ID: 23772304
Appl. No.: 05/446,363
Filed: February 27, 1974

Current U.S. Class: 210/136; 210/314; 210/359; 210/516; 210/789; 422/918
Current CPC Class: B01L 3/50215 (20130101)
Current International Class: B01L 3/14 (20060101); B01d 021/26 ()
Field of Search: ;23/23B,258.5,259,292 ;128/2F,214R,218M,272 ;210/83,84,131,359,514-518,DIG.23,DIG.24,136,314 ;233/1A,1R,26

References Cited [Referenced By]

U.S. Patent Documents
2305278 December 1942 Smith
3508653 April 1970 Coleman
3539300 November 1970 Stone
3586064 June 1971 Brown
3661265 May 1972 Greenspan
3682596 August 1972 Stone
3782548 January 1974 Bowen
3814248 June 1974 Lawhead
3832141 August 1974 Haldopoulos
Primary Examiner: Spear, Jr.; Frank A.
Assistant Examiner: Mukai; Robert G.
Attorney, Agent or Firm: Kane, Dalsimer, Kane, Sullivan and Kurucz

Claims



I claim:

1. A self-contained fluid separator assembly capable of separating blood into its component light phase of plasma or serum and heavy phase or cellular portion comprising:

a. a container having a first open end which is adapted to receive blood for subsequent separation into a light phase and a heavy phase and a second open end for removing the separated light phase;

b. closures sealing the open ends of the container, the closures being formed of a self sealing elastomeric material which is penetrable by a cannula;

c. a piston having a specific gravity relatively greater than the cellular portion of the blood and slidably mounted in the container and having means on an outer surface for providing sealing engagement with an inner surface of the container;

d. pressure responsive valve means associated with said piston, said valve means being constructed and arranged to be normally closed when there is a minimum of pressure differential on opposite sides of the valve means and which automatically opens in response to a substantial pressure differential so that when said container is subjected to moderate centrifugal force the blood separates into its light phase and heavy phase but the piston stays in the upper portion of the container, and subsequently when increased centrifugal force is used the valve means automatically opens with the light phase passing up through the valve means enabling the piston to move down through the light phase while retaining sealing engagement with the inner surfaces of the container; and

e. filter and stop means associated with said piston which comprises a first filter member which has a porosity selected such that it will pass red blood corpuscles and serum therethrough but will not pass fibrin and fibrous constituents of blood and a second filter member which has a porosity selected such that it will pass serum but will not pass red blood corpuscles therethrough; said first filter being mounted on said piston in a position wherein the light phase of the blood which is filtered passes therethrough before contacting said second filter member.

2. The self-contained fluid separator of claim 1 wherein said container comprises a tubular body open at each end in which closures formed of elastomeric material are mounted in sealing engagement with the tubular body and a piston disposed adjacent one of said closures.

3. The self-contained fluid separator of claim 1 wherein the piston includes a rigid tubular sleeve mounted in a generally tubular body portion formed of elastomeric material and having a plurality of spaced axial sealing rings on its outer portion for sealing engagement with the inner wall of the container and a diaphragm forming a wall across one end of the generally tubular elastomeric sleeve and wherein said valve means is comprised of at least one resilient aperture formed in said diaphragm.
Description



BACKGROUND OF THE INVENTION

1. Field of the Invention

The invention concerns apparatus for the separation and isolation of blood plasma and blood serum from blood mixtures.

2. Brief Description of the Prior Art

It is known to separate blood into its component parts by centrifugation, particularly employing a sealed container such as is disclosed in U.S. Pat. No. 2,460,641. This patent discloses a container having a closure at its open end which is capable of being penetrated by a cannula through which blood passes into the container. Clinical laboratories have heretofore used this device to collect a blood sample for subsequent separation into a light phase, i.e. the serum or plasma and the heavy phase, i.e. the cellular portion. The light phase is then decanted from the cellular portion by any conventional means, for example by the use of a syringe fitted with a cannula, or a pipette, or the like.

An apparatus also heretofore employed for the separation of blood is disclosed in U.S. Pat. No. 3,508,653. This patent discloses a self-contained assembly for separation of body fluid such as blood in which a deformable piston is disposed in the container and is positioned initially adjacent the stopper for closing the container. After the blood to be separated is in the container the assembly is centrifuged. After the blood is separated, increased centrifugal force is applied to the container, the seal between the inner surface of the container and piston is broken and the piston is deformed, moving down through the light phase with the light phase passing solely around the lateral surfaces of the piston and the inner surfaces of the container. When the piston reaches the interface between the light phase and the heavy phase, the piston movement is stopped, the force is terminated, and the seal is re-established between the inner surface of the container and the resilient piston to present a barrier between the two phases.

Disclosed in my U.S. Pat. No. 3,779,383 is a serum-plasma separator wherein the piston component is disclosed as having a valve means in association therewith through which the light phase blood component passes during piston descent by centrifugation. In recognition of the fact that small particles of solid materials normally found in blood may be carried with liquid components through the valve means, a preferred embodiment of the apparatus disclosed in my U.S. Pat. No. 3,779,383 has a filter disposed in the passage leading to the valve means, however the filter element of my prior invention is not disclosed as a type which will also serve to stop the descent of the piston at the interface between the two blood phases.

By the present invention the requirement for a filter element is such that only light phase blood components pass through the valve means. The filter means also comprises a means of stopping the piston descent at the most desirable point, i.e. at the interface between the separated blood phases.

Other devices known to the art are generally the filtration devices which separate blood into its component phases such as those disclosed in U.S. Pat. Nos. 3,481,477 and 3,512,940.

SUMMARY OF THE INVENTION

The invention is a self-contained fluid separator assembly capable of separating blood into its component parts of plasma or serum and cellular portion, comprising:

a. a container having a first open end which is adapted to receive blood for subsequent separation into a light phase and a heavy phase and a second open end for removing the separated light phase;

b. closures sealing the open ends of the container, the closures being formed of a self-sealing elastomeric material which is penetrable by a cannula;

c. a piston having a specific gravity greater than the cellular portion of the blood and slidably mounted in the container and having means on an outer surface in sealing engagement with an inner surface of the container;

d. pressure responsive valve means associated with said piston, said valve means being normally closed when there is a minimum of pressure differential on different portions of the valve means and which automatically opens in response to a substantial pressure differential so that when said container is subjected to moderate centrifugal force the blood separates into its light phase and heavy phase but the piston stays in the upper portion of the container, and subsequently when increased centrifugal force is used the valve means automatically opens with the light phase passing up through the valve means enabling the piston to move down through the light phase while retaining sealing engagement with the inner surfaces of the container; and

e. filter and stop means associated with said piston which comprises a first filter member which will pass red blood corpuscles therethrough but will not pass fibrin and fibrous constituents of blood and a second filter member which will pass the light phase of blood but which will not pass red blood corpuscles therethrough.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a cross-sectional side elevational view of a separator assembly of the invention illustrating a cannula penetrating one of the closures through which blood is introduced into the container prior to separation.

FIG. 2 is a view similar to FIG. 1 illustrating the separation of the blood into the light phase and heavy phase with the piston halted at the interface between phases.

DETAILED DESCRIPTION OF THE INVENTION

For a better understanding of the invention, a description of the drawings of the illustrative embodiments is had, particularly with respect to the embodiments shown in FIGS. 1 and 2.

Referring to FIG. 1, it is seen that the separator assembly 10 comprises a tubular member or container 12 having mounted in each open end 11, 15 closures 14 and 16. Closures 14 and 16 are made of a self-sealing elastomeric material, such as rubber, which are capable of receiving cannula 18 penetrated therethrough as illustrated in FIG. 1, for conducting blood 5 into the container. When the cannula is removed the closure is resealed with no loss of blood 5 passing through the penetration portion as illustrated in FIG. 2.

Closure 14 is formed having a depending cylindrical body portion 20 and a flanged head portion 22 integrally formed therewith. Body portion 20 has a diameter slightly greater than the internal diameter of the container 12 so that closure 14 when mounted into end 11 provides a pressure fit to seal the end. Head portion 30 of stopper 16 is preferably shaped in the form of a hexagon and is slightly greater in diameter than body portion 28 which permits the assembly to be positioned on its side without danger of rolling. An axial recess 24 in stopper 14 is provided for easy access through the stopper, which reduces the force required to penetrate it with cannula 18.

Stopper 16 is formed preferably of the same material as stopper 14. Stopper 16 has a cylindrical body portion 28 and an integrally formed flange head portion 30.

As shown in FIG. 1, piston 40 is held in a position adjacent to stopper 16 by an interference fit between the inner surface 13 of container 12 and a plurality of axially spaced sealing rings 50. This is the normal position of piston 40 prior to separation of the blood mixture 5.

Piston 40 includes a tubular metal insert 52 which is mounted in annular recess 54 of piston 40. Metal insert 52 is preferably made of stainless steel or other rigid, chemically inert material having a specific gravity greater than blood. Piston 40 is formed of elastomeric material and is provided with annular recess 54 which is dimensioned to receive tubular member 52 in an interference fit so that no air space remains in annular recess 54.

The elastomeric portion of piston 40 comprises an outer wall 48 and spaced therefrom is inner wall 46 which defines annular recess 54. Formed integrally with wall 48 are a plurality of axially spaced sealing rings 50 which contact the inner wall surface 13 of container 12 in sealing engagement. Piston 40 when mounted in container 12 will maintain sealing contact with the inner surface 13 of container 12 throughout its path of travel within container 12, as hereinafter described. Integral with and joining the lateral inner wall 46 is top wall portion of diaphragm 44 which is pierced by at least one aperture 42. During the centrifuging operation piston 40 is subjected to centrifugal forces tending to slide the piston downwardly and such descent establishes a pressure differential on opposite sides of the diaphragm 44 of piston 40. Top wall portion or diaphragm 44 has a relatively small thickness and lies adjacent stopper 16 in its initial position as seen in FIG. 1.

Diaphragm 44 is made of a resilient material. Wall portion 46 and diaphragm 44 of piston 40 define an axial annular recess or throat 80 within piston 40 which leads from the lower surface 82 of piston 40 to apertures 42. As the assembly is being subjected to centrifugal forces the light phase which is separated from the blood will pass into throat 80 and be guided to apertures 42 as the piston descends through the light phase. Since the centrifugal forces acting on the descending piston 40 will generate hydrostatic force greater than the force of the light phase being exerted against the top of the diaphragm 44, apertures 42 will automatically open and will enable piston 40 to move from its initial position of FIG. 1, downward within the confines of container 12. Interposed in the flow path of light phase material to apertures 42 is a fine filter element 85 which has pore sizes which will not permit the passage of blood red cells, having an average diameter of about 7 microns. This element 85 serves as a stop means to halt the descent of piston 40 once it reaches the interface between the separated lighter and heavier phases as will be discussed more fully hereinafter. Affixed beneath filter 85 there is a different filter element 90 characterized by pore sizes which will allow the passage of red blood cells but will not allow the passage of particulate matter such as, for example fibrin. The filter element 90 as shown in FIG. 1 may have an interior chamber portion to provide increased filter surface area. This is a preferred form of filter element 90. However a filter element 90 completely filling the remaining void in throat 80 may alternatively be employed.

In operation, the light phase passing through filter 90 on its way to apertures 42 is filtered to remove particles of fibrin and other particulate matter. When piston 40 reaches the heavy phase, red blood corpuscles contained therein pass into throat 80, through filter 90 and are stopped from further passage by the red-blood cell impervious filter element 85. As the red blood cells build up on the surface of filter 85, they clog the filter and prevent the continued flow of fluid to apertures 42. The reduction of flow and the further incompressibility of the heavy phase halts further descent of piston 40. This occurs when the piston 40 has reached a point in its descent approximating the interface between light 5a and heavy 5b separated blood phases as seen in FIG. 2. When piston 40 stops its movement in container 12 and comes to rest at the aforementioned interface, the pressure differential on each side of diaphragm 44 is substantially equalized and valve means 42 automatically shifts from the open position to the closed position even though the assembly may continue to be subjected to centrifugal forces.

As illustrated in FIG. 2, piston 40 has completed its travel within container 12 and is stopped from further movement in container 12 by the clogging of filter 85, which acts as a stop means. With the valve aperture means 42 closed, the piston 40 forms an impermeable barrier between the now separated and isolated phases.

Fine filter element 85 may be made of any conventional filter material capable of preventing the passage of red blood corpuscles (which have an average effective diameter of about 7 microns) but which will allow the passage of blood serum or blood plasma. The materials employed should not produce any undesirable reaction with blood. Illustrative of filter materials for filter 90 which may be employed are asbestos, compacted fibers of polyolefins, plastic foams such as polyurethane foams, polyethylene foams and the like; sintered glass and sintered polyethylene.

When operating the separator assembly of the invention herein it is preferred that the assembly be first evacuated of air so that when cannula 18 penetrates closure 14 blood 5 will automatically fill container 12. After cannula 18 is withdrawn and container 12 is filled with blood the assembly may be placed in a centrifuge and is separated into light and heavy phases by employing relatively low centrifugal forces which do not cause the piston to move from its initial position. Thereafter the rotational speed of the centrifuge is increased which causes descent of piston 40 through the light phase. When the centrifugal forces are terminated, the separated and phase isolated blood samples are ready for use in a conventional manner for the diagnosis of physical ailments.

* * * * *


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed